Lycia Completes $106.6M Series C For LYTAC Protein Degraders
13 May 2024 //
GLOBENEWSWIRE
Lycia Therapeutics to Present at Jefferies Healthcare Conference
13 May 2024 //
PRESS RELEASE
Lycia Therapeutics to Present at Jefferies Healthcare Conference
05 Jun 2023 //
GLOBENEWSWIRE
Lycia Therapeutics Founder Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize
05 Oct 2022 //
GLOBENEWSWIRE
Lycia Tx Appoints Steve Staben, Ph.D. as CSO
28 Feb 2022 //
GLOBENEWSWIRE
Lilly-backed Lycia Therapeutics nabs $70M round
09 Sep 2021 //
FIERCEBIOTECH
Lilly doubles down on protein degradation with $35M Lycia deal
26 Aug 2021 //
FIERCEBIOTECH